Register for real-time alerts, custom portfolio, and market movers

Get Started

RE Everest Re Group Ltd

351.28

0.00 (0.00%)

Pre Market

Last Updated: 20:00:00

Delayed by 15 minutes

AbbVie and REGENXBIO team up for eye disease therapy in $1.5 billion deal

To read the full story on Seeking Alpha, click here.

Everest Re (NYSE:RE)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Everest Re Charts.

Everest Re (NYSE:RE)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Everest Re Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Everest Re Group Ltd News

More Everest Re Group Ltd News Articles

FuelCell Energy

Therapeutic Solutions (PK)

NaturalShrimp (QB)

Federal Home Loan Mortgage (QB)

MicroCloud Hologram

Yuenglings Ice Cream (PK)

Seafarer Exploration (PK)

Anavex Life Sciences

Globestar Therapeutics (PK)

Decentral Life (PK)

Delayed Upgrade Clock